Print   

Monday 01 February, 2010

Skyepharma PLC

Share Purchase Plan

RNS Number : 4920G
Skyepharma PLC
01 February 2010
 



For Immediate Release

1 February 2010

 

SkyePharma PLC ("the Company")

 

The Company was informed on 1 February 2010 that as a result of transactions on 29 January 2010 by the SkyePharma PLC Share Purchase Plan (the "Plan") (an approved all employee share purchase plan) the Trustees of the Plan purchased an additional 3,596 Ordinary Shares of the Company at a price of £0.79 per share.

 

As a result of these transactions, Peter Grant, a Director of the Company, has the following additional interests as a result of his personal participation in the Plan:-

 

Partnership Shares  purchased on 29 January 2010 at £0.79 per share

Matching Shares  awarded on 29 January 2010

at £0.79 per share

Total number of Partnership and Matching Shares held on 29 January 2010

158

158

3,899

 

In accordance with the rules of the Plan, Mr Grant has been awarded Matching Shares on the basis of one Matching Share (Ordinary Share) for each Partnership Share (Ordinary Share). 

 

The beneficial ownership of the Matching Shares will pass to Mr Grant in three years' time subject to continued employment and the retention of the underlying Partnership Shares.

 

The execution of the transaction noted above did not involve any of the Company's Directors or any persons discharging managerial responsibility.

 

This notification relates to transactions notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSSDFWFFSSEEE

Investegate takes no responsibility for the accuracy of the information within the site.


The announcements are supplied by the denoted source. Queries about the content of an announcement should be directed to the source. Investegate reserves the right to publish a filtered set of announcements. NAV, EMM/EPT, Rule 8 and FRN Variable Rate Fix announcements are filitered from this site.



Investegate      © 2012 FE. All rights reserved.